Dr John Nash, Senior Director ADME/PK, BioFocus

pharmafile | November 3, 2009 | Appointment | Research and Development |  appointment, biofocus, research and development 

BioFocus, a leading provider of gene-to-drug candidate discovery services, has appointed Dr John Nash as senior director, ADME/PK. 

John has 30 years industrial experience with both service and major pharma companies.

Most recently, John worked for eight years for Charles River Laboratories in Quebec, Canada, where he was responsible for strengthening the DMPK service business, and making it a successful, revenue generating operation.  Prior to moving to Canada, John worked in the UK with Anserve and AstraZeneca/Syngenta in metabolism and pharmacokinetics. John holds an M. Phil. degree from the University of Surrey and a Ph.D. degree from the University of Manchester.

“John Nash’s appointment is a major win for BioFocus in the UK,” commented Dr Chris Newton, SVP BioFocus. “With this hire, BioFocus continues to elevate its 175 scientist facility at Chesterford Research Park into a leading integrated discovery research center for pharma, biotech and not-for-profit organisations worldwide.”